NIDAN LABS AND HEALTH LTD Financial Ratios
NIDAN · Healthcare · Current price ₹13.15
P/E ratio
8.8x
P/B ratio
0.3x
ROE
2.9%
ROCE
22.2%
Debt / Equity
0.16
Dividend yield
0.0%
Ratio reference
| Ratio | Value | What it means |
|---|---|---|
| P/E | 8.8x | Price paid per ₹1 of annual earnings — lower is cheaper (context-dependent). |
| P/B | 0.3x | Price relative to book value — <1 can signal deep value or trouble. |
| ROE | 2.9% | Return on equity — how much profit the company earns on shareholder capital. |
| ROCE | 22.2% | Return on capital employed — efficiency including debt. >15% is strong. |
| D/E | 0.16 | Leverage — higher means more debt-funded, riskier in downturns. |
Model it yourself — PEG Ratio Calculator
Opens pre-filled with NIDAN LABS AND HEALTH LTD's latest numbers.
NIDAN LABS AND HEALTH LTD profitability
NIDAN LABS AND HEALTH LTD generates a return on equity of 2.9% and a return on capital employed of 22.2%. An ROE consistently above 15% usually points to a quality business with a durable advantage; below 10% suggests weak profitability or a capital-heavy model.
Leverage & valuation
With a debt-to-equity of 0.16 and a P/E of 8.8x, NIDAN LABS AND HEALTH LTD is conservatively financed. Our overall business-quality score for the company is 4.2 / 10.
Understand the ratios
More on NIDAN LABS AND HEALTH LTD
DocStoX estimates are generated by a deterministic valuation engine from reported financials — for informational purposes only, not investment advice. Consult a SEBI-registered advisor before investing.